University Medical Center
Welcome,         Profile    Billing    Logout  
 4 Trials 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Schramm, Patrick
ARISS, NCT03869385: Albumin Replacement Therapy in Septic Shock

Terminated
3
440
Europe
AlbuteinĀ® 200 g/L or PlasbuminĀ® 20, Human Albumin 20%
Jena University Hospital, German Research Foundation, Instituto Grifols, S.A., University Hospital Goettingen, SepNet - Critical Care Trials Group, Center for Sepsis Control and Care, Germany
Septic Shock
07/22
06/23
SepsAR3, NCT04259567: Improvement of Cerebrovascular Autoregulation in Patients With Septic Shock Due to Cytokine Elimination

Recruiting
N/A
150
Europe
Cytokine absorption
Johannes Gutenberg University Mainz
Septic Shock
12/21
07/22

Download Options